WallStreetZenWallStreetZen

NASDAQ: MPLT
Maplight Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Maplight Therapeutics earnings were -$229.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest MPLT earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$60.2M, down 0.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MPLT reported annual earnings of -$161.2M, with 107.7% growth. The next MPLT earnings date is Dec 3, 2026.

MPLT earnings history

Current Revenue
$0.0
Current Earnings
-$229.8M
Current Profit Margin
0%

MPLT Return on Equity

Current Company
-98.6%
Current Industry
-10.8%
Current Market
30.9%
MPLT's Return on Equity (-98.6%)... subscribe to Premium to read more.
High Return on Equity Performance

MPLT Return on Assets

Current Company
-60.3%
Current Industry
-10.7%
MPLT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MPLT announces earnings.

MPLT Return on Capital Employed

Current Company
-65.84%
Current Industry
-7.4%

MPLT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MPLT-$228.36M-$229.83MN/A$47.30
CYPH$1.26M-$877.00kN/A$0.59
GALT-$20.04M-$28.03MN/A-$0.43
KYTX-$146.83M-$152.64MN/A-$2.93
SPRY-$206.37M-$215.43MN/A-$2.18
View Top Biotech Stocks

MPLT earnings dates

Next earnings date
Dec 3, 2026

Maplight Therapeutics Earnings Reports & History FAQ

What were Maplight Therapeutics's earnings last quarter?

On MPLT's earnings call on Aug 13, 2026, Maplight Therapeutics (NASDAQ: MPLT) reported Q2 2026 earnings per share (EPS) of -$1.32, up 96.62% year over year. Total MPLT earnings for the quarter were -$60.19 million. In the same quarter last year, Maplight Therapeutics's earnings per share (EPS) was -$39.11.

If you're new to stock investing, here's how to buy Maplight Therapeutics stock.

When does Maplight Therapeutics report earnings?

The next MPLT earnings call is Dec 3, 2026. Add MPLT to your watchlist to be reminded of Maplight Therapeutics's next earnings date.

Is Maplight Therapeutics profitable or losing money?

As of the last Maplight Therapeutics earnings report, Maplight Therapeutics is currently losing money. Maplight Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$229.83 million, a 148.65% increase year over year.

What was MPLT's earnings growth in the past year?

As of Maplight Therapeutics's earnings date in Aug 13, 2026, Maplight Therapeutics's earnings has grown year over year. MPLT earnings in the past year totalled -$229.83 million.

What are Maplight Therapeutics's earnings expectations?

The current EPS estimate for Maplight Therapeutics's earnings report in Dec 3, 2026 is -$1.22.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.